Abbott Laboratories (ABT) Financials
Abbott Laboratories (ABT) Historical Financial Statements and Key Metrics for 1990 - 2020
Full Abbott Laboratories financials for 1990 - 2020 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Abbott Laboratories Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2020-Sep-30 | 8,853 | 4,887 (55.2 %) | 1,495 (16.1 %) | 1,232 (13.9 %) | 2,359 | 0.69 |
| 2020-Jun-30 | 7,328 | 4,065 (55.5 %) | 672 (7.2 %) | 537 (7.3 %) | 1,484 | 0.30 |
| 2020-Mar-31 | 7,726 | 4,449 (57.6 %) | 808 (10.5 %) | 564 (7.3 %) | 1,620 | 0.32 |
| 2019-Dec-31 | 8,314 | 4,897 (58.9 %) | 1,326 (15.9 %) | 1,049 (12.6 %) | 2,168 | 0.59 |
| 2019-Sep-30 | 8,076 | 4,720 (58.4 %) | 1,198 (14.8 %) | 960 (11.9 %) | 2,024 | 0.54 |
| 2019-Jun-30 | 7,979 | 4,700 (58.9 %) | 1,206 (15.1 %) | 1,006 (12.6 %) | 2,021 | 0.56 |
| 2019-Mar-31 | 7,535 | 4,391 (58.3 %) | 739 (9.8 %) | 672 (8.9 %) | 1,634 | 0.38 |
Full historical income statements for 1990 - 2020 is included in the
US Historical Financials dataset.
Abbott Laboratories Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2020-Sep-30 | 69,043 | 37,448 | 18,563 | 31,386 | 4,731 |
| 2020-Jun-30 | 68,776 | 38,198 | 19,679 | 30,578 | 5,037 |
| 2020-Mar-31 | 66,777 | 36,559 | 18,272 | 30,218 | 3,668 |
| 2019-Dec-31 | 67,887 | 36,799 | 18,139 | 31,088 | 4,140 |
| 2019-Sep-30 | 68,539 | 36,722 | 19,097 | 31,817 | 4,335 |
| 2019-Jun-30 | 68,427 | 36,741 | 19,194 | 31,686 | 3,376 |
| 2019-Mar-31 | 67,610 | 36,685 | 19,054 | 30,925 | 3,261 |
Full historical balance sheet data for 1990 - 2020 is included in the
US Historical Financials dataset.
Abbott Laboratories Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2020-Sep-30 | 2,066 | 0 | 0 | 1,570 |
| 2020-Jun-30 | 1,322 | 0 | 0 | 680 |
| 2020-Mar-31 | 715 | -393 | -735 | 355 |
| 2019-Dec-31 | 2,416 | -489 | -2,185 | 1,982 |
| 2019-Sep-30 | 1,948 | -432 | -513 | 1,547 |
| 2019-Jun-30 | 1,060 | -498 | -449 | 592 |
| 2019-Mar-31 | 712 | -396 | -1,142 | 377 |
Full historical cash flow data for 1990 - 2020 is included in the
US Historical Financials dataset.
Abbott Laboratories Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2020-Sep-30 | 192,886 | 207,006 | 21.79 | 156.56 | 6.15 |
| 2020-Jun-30 | 161,253 | 174,879 | 22.01 | 300.29 | 5.27 |
| 2020-Mar-31 | 139,375 | 153,006 | 18.04 | 247.12 | 4.61 |
| 2019-Dec-31 | 152,855 | 165,857 | 18.39 | 145.71 | 4.92 |
| 2019-Sep-30 | 146,865 | 160,617 | 18.19 | 152.98 | 4.62 |
| 2019-Jun-30 | 147,524 | 163,573 | 18.49 | 146.64 | 4.66 |
| 2019-Mar-31 | 138,147 | 154,171 | 18.33 | 205.58 | 4.47 |
Full historical valuation and operating metrics for 1990 - 2020 are included in the
US Historical Financials dataset.